HC Wainwright & Co. Maintains Buy on Armata Pharmaceuticals, Raises Price Target to $15
Benzinga Newsdesk 8 months ago
NewsPrice TargetAnalyst Ratings
HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and raises the price target from $9 to $15.
HC Wainwright & Co. analyst Joseph Pantginis maintains Armata Pharmaceuticals (AMEX:ARMP) with a Buy and raises the price target from $9 to $15.